| MEDEXUS PHARMACEUTIC. |
| Kanada |
| Gesundheit |
| CA58410Q2036 / A2PA3U |
| P731 (Frankfurt) |
| FRA:P731, ETR:P731, P731:GR |
| - |
| https://www.medexus.com/ |
|
Medexus Pharmaceuticals Inc. is a North American specialty pharmaceutical company that primarily focuses on providing innovative and niche products within the realms of hematology, autoimmune diseases, and allergy markets. Its portfolio includes both..
>Volltext.. |
| 69.87 Mio. EUR |
| 78.84 Mio. EUR |
| 87.68 Mio. EUR |
| 11.23 Mio. EUR |
| -0.25 Mio. EUR |
| -0.01 EUR |
| 21.92 Mio. EUR |
| 12.95 Mio. EUR |
| 13.18 Mio. EUR |
| 0.24 |
| -3% |
| -108.61% |
| - |
| - |
| - |
| - |
| MEDEXUS |
| 05.04.26 |
|